Edward White
Stock Analyst at HC Wainwright & Co.
(1.91)
# 3,235
Out of 5,149 analysts
338
Total ratings
31.92%
Success rate
-7.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $15.73 | +109.79% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $10.25 | +65.85% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $3.75 | +300.00% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.89 | +54.24% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $0.99 | +1,516.00% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.91 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $29.00 | +175.86% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $2.36 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $5.47 | +265.63% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $4.44 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $5.51 | +190.38% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.24 | +300.64% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.91 | +776.81% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $18.85 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.02 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $28.88 | +90.44% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $21.40 | +138.32% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $6.21 | +12.72% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $9.13 | +513.36% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | $10.24 | +407.81% | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.71 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $34.31 | -12.56% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.37 | +775.91% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $15.73
Upside: +109.79%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $10.25
Upside: +65.85%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $3.75
Upside: +300.00%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.89
Upside: +54.24%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $0.99
Upside: +1,516.00%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.91
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $29.00
Upside: +175.86%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.36
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $5.47
Upside: +265.63%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.44
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $5.51
Upside: +190.38%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.24
Upside: +300.64%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $0.91
Upside: +776.81%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $18.85
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.02
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $28.88
Upside: +90.44%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $21.40
Upside: +138.32%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $6.21
Upside: +12.72%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $9.13
Upside: +513.36%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: $10.24
Upside: +407.81%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.71
Upside: -
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $34.31
Upside: -12.56%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.37
Upside: +775.91%